Suppr超能文献

感染性发作后自身免疫性肺泡蛋白沉积症的暂时缓解

Temporary remission of autoimmune pulmonary alveolar proteinosis after infectious episodes.

作者信息

Kobayashi Takehiko, Arai Toru, Hirose Masaki, Homma Tomomi, Matsumuro Akiko, Sugimoto Chikatoshi, Kitaichi Masanori, Akira Masanori, Inoue Yoshikazu

机构信息

Department of Internal Medicine.

Clinical Research Center.

出版信息

Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):85-90. doi: 10.36141/svdld.v34i1.5086. Epub 2017 Apr 28.

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disease of unknown aetiology. Although resolution occurs in about 30% of autoimmune PAP (APAP) cases, its pathogenesis is not yet sufficiently understood. Two APAP cases at our institute showed remission following infectious episodes. Case 1: a 40-year-old female APAP patient suffered from herpes encephalitis and was treated with an antiviral drug. Her symptoms and radiological results resolved within two months of her recovery from the encephalitis. Case 2: A 53-year-old male current-smoker APAP patient was admitted for pneumonia. After treatment with antibiotics, his radiological results and symptoms improved. He experienced a similar resolution of APAP after another infectious episode two years later. Remission of APAP may occur following viral or bacterial infection. We hypothesise that remission of APAP is triggered by the induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) following viral or bacterial infection. Further studies of APAP remission, and especially of the effects of GM-CSF induction, are needed. .

摘要

肺泡蛋白沉积症(PAP)是一种病因不明的罕见疾病。虽然约30%的自身免疫性PAP(APAP)病例可自行缓解,但其发病机制尚未得到充分了解。我院的两例APAP病例在感染性疾病发作后病情缓解。病例1:一名40岁的女性APAP患者患疱疹性脑炎,接受了抗病毒药物治疗。她的症状和影像学结果在从脑炎康复后的两个月内得到缓解。病例2:一名53岁的男性现吸烟者APAP患者因肺炎入院。使用抗生素治疗后,他的影像学结果和症状有所改善。两年后,在另一次感染性疾病发作后,他的APAP病情出现了类似的缓解。APAP可能在病毒或细菌感染后缓解。我们推测,APAP的缓解是由病毒或细菌感染后粒细胞-巨噬细胞集落刺激因子(GM-CSF)的诱导所触发的。需要对APAP的缓解情况,尤其是GM-CSF诱导的影响进行进一步研究。

相似文献

1
Temporary remission of autoimmune pulmonary alveolar proteinosis after infectious episodes.
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):85-90. doi: 10.36141/svdld.v34i1.5086. Epub 2017 Apr 28.
2
Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode.
Intern Med. 2023 Aug 1;62(15):2237-2241. doi: 10.2169/internalmedicine.1592-23. Epub 2023 May 10.
5
Pulmonary alveolar proteinosis: time to shift?
Expert Rev Respir Med. 2015 Jun;9(3):337-49. doi: 10.1586/17476348.2015.1035259. Epub 2015 Apr 12.
6
A case of autoimmune pulmonary alveolar proteinosis with fluctuating lung shadows in parallel with cigarette smoke burden.
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(3):257-259. doi: 10.36141/svdld.v34i3.5815. Epub 2020 Mar 9.
7
Viral pneumonia and pulmonary alveolar proteinosis: the cause and the effect, case report.
AME Case Rep. 2019 Oct 16;3:41. doi: 10.21037/acr.2019.09.04. eCollection 2019.
8
Clinical significance of serum anti-GM-CSF autoantibody levels in autoimmune pulmonary alveolar proteinosis.
Biomark Med. 2018 Feb;12(2):151-159. doi: 10.2217/bmm-2017-0362. Epub 2017 Dec 5.
9
Role of granulocyte-macrophage colony-stimulating factor in pulmonary fibrosis following pulmonary alveolar proteinosis.
Respirol Case Rep. 2016 May 5;4(4):e00159. doi: 10.1002/rcr2.159. eCollection 2016 Jul.

引用本文的文献

1
Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode.
Intern Med. 2023 Aug 1;62(15):2237-2241. doi: 10.2169/internalmedicine.1592-23. Epub 2023 May 10.
2
Viral pneumonia and pulmonary alveolar proteinosis: the cause and the effect, case report.
AME Case Rep. 2019 Oct 16;3:41. doi: 10.21037/acr.2019.09.04. eCollection 2019.

本文引用的文献

1
Autoimmune Pulmonary Alveolar Proteinosis Following Pulmonary Aspergillosis.
Intern Med. 2015;54(24):3177-80. doi: 10.2169/internalmedicine.54.5034. Epub 2015 Dec 15.
2
Opportunistic infections in patients with pulmonary alveolar proteinosis.
J Infect. 2012 Aug;65(2):173-9. doi: 10.1016/j.jinf.2012.03.020. Epub 2012 Apr 4.
4
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1345-54. doi: 10.1164/rccm.200906-0978OC. Epub 2010 Feb 18.
5
Resolution of secondary pulmonary alveolar proteinosis following treatment of rhinocerebral aspergillosis.
Int J Infect Dis. 2010 Sep;14 Suppl 3:e246-9. doi: 10.1016/j.ijid.2009.10.004. Epub 2010 Feb 1.
6
Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.
N Engl J Med. 2009 Dec 31;361(27):2679-81. doi: 10.1056/NEJMc0904077.
8
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.
Am J Respir Crit Care Med. 2008 Apr 1;177(7):752-62. doi: 10.1164/rccm.200708-1271OC. Epub 2008 Jan 17.
9
Systemic cytokine profile in children with community-acquired pneumonia.
Pediatr Pulmonol. 2007 Jul;42(7):640-5. doi: 10.1002/ppul.20633.
10
Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
Am J Respir Crit Care Med. 2005 May 15;171(10):1142-9. doi: 10.1164/rccm.200406-716OC. Epub 2005 Feb 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验